These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

648 related items for PubMed ID: 22810055

  • 1. Are anti-nucleosome antibodies a better diagnostic marker than anti-dsDNA antibodies for systemic lupus erythematosus? A systematic review and a study of metanalysis.
    Bizzaro N, Villalta D, Giavarina D, Tozzoli R.
    Autoimmun Rev; 2012 Dec; 12(2):97-106. PubMed ID: 22810055
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Anti-nucleosome antibodies in patients with systemic lupus erythematosus: potential utility as a diagnostic tool and disease activity marker and its comparison with anti-dsDNA antibody.
    Saigal R, Goyal LK, Agrawal A, Mehta A, Mittal P, Yadav RN, Meena PD, Wadhvani D.
    J Assoc Physicians India; 2013 Jun; 61(6):372-7. PubMed ID: 24640201
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Assessment of anti-nucleosome antibody (ANuA) isotypes for the diagnosis and prediction of systemic lupus erythematosus and lupus nephritis activity.
    Zeng Y, Xiao Y, Zeng F, Jiang L, Yan S, Wang X, Lin Q, Yu L, Lu X, Zhang Y, Lin Y.
    Clin Exp Med; 2023 Sep; 23(5):1677-1689. PubMed ID: 36385418
    [Abstract] [Full Text] [Related]

  • 6. Anti-nucleosome antibodies in patients with systemic lupus erythematosus of recent onset. Potential utility as a diagnostic tool and disease activity marker.
    Simón JA, Cabiedes J, Ortiz E, Alcocer-Varela J, Sánchez-Guerrero J.
    Rheumatology (Oxford); 2004 Feb; 43(2):220-4. PubMed ID: 13130152
    [Abstract] [Full Text] [Related]

  • 7. Anti-nucleosome antibodies as a disease activity marker in patients with systemic lupus erythematosus.
    Suleiman S, Kamaliah D, Nadeem A, Naing NN, Che Maraina CH.
    Int J Rheum Dis; 2009 Jul; 12(2):100-6. PubMed ID: 20374326
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Anti-nucleosome antibodies as a disease marker in systemic lupus erythematosus and its correlation with disease activity and other autoantibodies.
    Pradhan VD, Patwardhan MM, Ghosh K.
    Indian J Dermatol Venereol Leprol; 2010 Jul; 76(2):145-9. PubMed ID: 20228543
    [Abstract] [Full Text] [Related]

  • 11. Diagnostic value of anti-nucleosome antibodies in the assessment of disease activity of systemic lupus erythematosus: a prospective study comparing anti-nucleosome with anti-dsDNA antibodies.
    Gutiérrez-Adrianzén OA, Koutouzov S, Mota RM, das Chagas Medeiros MM, Bach JF, de Holanda Campos H.
    J Rheumatol; 2006 Aug; 33(8):1538-44. PubMed ID: 16783863
    [Abstract] [Full Text] [Related]

  • 12. The impact of biological treatments on the anti-dsDNA and anti-nucleosome tests.
    Infantino M, Grossi V, Benucci M, Li Gobbi F, Damiani A, Manfredi M.
    Lupus; 2018 Jan; 27(1):40-48. PubMed ID: 28587585
    [Abstract] [Full Text] [Related]

  • 13. Clinical and serological correlates of antinucleosome antibodies in South Africans with systemic lupus erythematosus.
    Tikly M, Gould T, Wadee AA, van der Westhuizen E, Mokgethwa BBN.
    Clin Rheumatol; 2007 Dec; 26(12):2121-2125. PubMed ID: 17516129
    [Abstract] [Full Text] [Related]

  • 14. Anti-C1q, anti-chromatin/nucleosome, and anti-dsDNA antibodies in juvenile systemic lupus erythematosus patients.
    Jesus AA, Campos LM, Liphaus BL, Carneiro-Sampaio M, Mangueira CL, Rosseto EA, Silva CA, Scheinberg M.
    Rev Bras Reumatol; 2012 Dec; 52(6):976-81. PubMed ID: 23223707
    [Abstract] [Full Text] [Related]

  • 15. TSH receptor autoantibody immunoassay in patients with Graves' disease: improvement of diagnostic accuracy over different generations of methods. Systematic review and meta-analysis.
    Tozzoli R, Bagnasco M, Giavarina D, Bizzaro N.
    Autoimmun Rev; 2012 Dec; 12(2):107-13. PubMed ID: 22776786
    [Abstract] [Full Text] [Related]

  • 16. The relevance of autoantigen source and cutoff definition in antichromatin (nucleosome) antibody immunoassays.
    Villalta D, Tozzoli R, Bizzaro N, Tonutti E, Ghirardello A, Doria A.
    Ann N Y Acad Sci; 2005 Jun; 1050():176-84. PubMed ID: 16014532
    [Abstract] [Full Text] [Related]

  • 17. [Evaluation of cut-off value for autoantibodies against double-stranded DNA-complexed nucleosomes based on enzyme linked immunosorbent assay].
    Ohnuma K, Hayashi N, Fukuzumi N, Saito A, Tanaka M, Kumagai S, Kawano S.
    Rinsho Byori; 2014 Mar; 62(3):223-30. PubMed ID: 24800496
    [Abstract] [Full Text] [Related]

  • 18. [The role of anti-nucleosome antibodies in systemic lupus erythematosus. Results of a study of patients with systemic lupus erythematosus and other connective tissue diseases].
    Quattrocchi P, Barrile A, Bonanno D, Giannetto L, Patafi M, Tigano V, Ferlazzo B.
    Reumatismo; 2005 Mar; 57(2):109-13. PubMed ID: 15983634
    [Abstract] [Full Text] [Related]

  • 19. Anti-nucleosome antibodies in the diagnosis of systemic lupus erythematosus.
    Julkunen H, Salonen EM, Walle TK, Miettinen A.
    Scand J Rheumatol; 2005 Mar; 34(2):122-4. PubMed ID: 16095007
    [Abstract] [Full Text] [Related]

  • 20. Cut-off values of immunological tests to identify patients at high risk of severe lupus nephritis.
    Gargiulo MLÁ, Khoury M, Gómez G, Grimaudo S, Suárez L, Collado MV, Sarano J.
    Medicina (B Aires); 2018 Mar; 78(5):329-335. PubMed ID: 30285925
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.